Oncolytics Biotech, Inc.
(Toronto Stock Exchange : ONCY)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 0.18%131.450.0%$1318.87m
OCGNOcugen, Inc. -15.58%8.830.0%$1058.59m
NVAXNovavax, Inc. -12.92%159.8992.9%$628.04m
AMGNAmgen, Inc. -0.56%222.681.3%$545.87m
VRTXVertex Pharmaceuticals, Inc. -0.09%208.261.9%$518.42m
REGNRegeneron Pharmaceuticals, Inc. 0.39%448.452.7%$505.13m
GILDGilead Sciences, Inc. 1.22%63.521.0%$485.96m
ILMNIllumina, Inc. -3.68%401.093.5%$458.95m
ALXNAlexion Pharmaceuticals, Inc. -0.23%147.852.0%$340.74m
BIIBBiogen, Inc. -0.32%265.751.7%$319.40m
CRSPCRISPR Therapeutics AG -3.91%114.420.6%$271.86m
BNGOBionano Genomics, Inc. -19.42%6.890.0%$243.67m
EXASEXACT Sciences Corp. -4.32%121.1018.4%$225.84m
SGENSeagen Inc. -0.82%146.725.8%$207.31m
PACBPacific Biosciences of California, Inc. -6.59%28.937.2%$153.06m

Company Profile

Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor lysis, and promotes an inflamed tumor phenotype through innate and adaptive immune responses. The company was founded by Matthew C. Coffey and Bradley George Thompson on April 2, 1998 and is headquartered in Calgary, Canada.